No profile data available.
Avidity Biosciences, Inc. (RNA) is a healthcare company in the multi-therapeutic drug manufacturing industry, based in San Diego, United States.
It reported revenue of $18.62 million for fiscal year 2025, up 70.9% from fiscal year 2024, and net income of -$76.68 million. Its market capitalization was $143.69 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, a biopharmaceutical company, focuses on delivering ribonucleic acid (RNA) therapeutics to the heart to transform the care for people living with cardiomyopathies.
Avidity Biosciences reported $18.62 million in revenue for fiscal year 2025, up 70.9% from $10.90 million in fiscal year 2024.
$143.69 million as of October 9, 2026.
Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include Protara Therapeutics, Inc. (TARA), Tiziana Life Sciences Ltd (TLSA), Korro Bio, Inc. (KRRO), vTv Therapeutics Inc. (VTVT).